<DOC>
	<DOCNO>NCT01194453</DOCNO>
	<brief_summary>A phase III trial demonstrate advanced non-small cell lung cancer ( NSCLC ) cisplatin/ pemetrexed provide similar efficacy well tolerability convenient administration cisplatin/gemcitabine . Moreover , trial show survival difference base histologic type . The investigator want research biomarkers predict clinical outcome .</brief_summary>
	<brief_title>Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin Advanced NSCLC Metastatic Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>1 . Chemotherapynaive patient histologically cytologically confirm adenocarcinoma largecell carcinoma , classify stage IIIB amenable curative treatment stage IV 2 . With least one unidimensionally measurable lesion accord Response Evaluation Criteria Solid Tumors ; 3. Eastern CooperativeOncology Group performance status 0 1 , 4 . At least 18 year age 5. adequate bone marrow reserve organ function include calculated creatinine clearance 45 mL/min base standard Cockcroft Gault formula . 6 . Prior radiation therapy permit complete least 4 week study treatment 7. patient fully recover acute effect . 1. peripheral neuropathy &gt; National Cancer Institute Common Toxicity Criteria grade 1 2. progressive brain metastasis , 3. uncontrolled thirdspace fluid retention study entry . 4 . Patients unable interrupt aspirin nonsteroidal antiinflammatory drug unable unwilling take folic acid , vitamin B12 , corticosteroid .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>